Early Access — free while we kick the tires
EdgarHawk

Frankenius Equity AB

10% Owner

10% Owner
1 filing analyzed · 1 company · Latest 2024-12-19

Companies

Company Buys Sells Direction
TriSalus Life Sciences, Inc. TLSI 1 0 Net buying

Activity

December 2024
medium
Buy
62,972 shares
$249,999
Significance 5/10

10% owner Frankenius Equity AB purchased 62,972 shares of TLSI at $3.97, boosting stake to 6.23M shares amid 64.9% decline from 52-week high.

Frankenius Equity AB, a 10% shareholder, acquired 62,972 shares at $3.97 on 2024-12-17, expanding holdings to 6,230,748 shares. The purchase occurs after the stock has declined 64.9% from its 52-week high of $10.25 and fallen 12.6% in the preceding 30 days. While the company demonstrates revenue growth of 49.3% year-over-year and recent quarterly revenue of $7,349,000.00, it remains unprofitable with a quarterly net loss of $-2,399,000.00. The transaction represents a $249,998.84 investment by a major stakeholder at a significantly depressed valuation relative to recent price levels.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access